Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Hikma Pharmaceuticals Launches Prefilled Syringe Capability | Contract Pharma

What are you searching for?

Sign in
Breaking News

Hikma Pharmaceuticals Launches Prefilled Syringe Capability

First Hikma medicine available in prefilled syringe form is Heparin Sodium Injection, USP, 5000 Units/mL

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Hikma Pharmaceuticals has launched a new prefilled syringe capability in the U.S. through its affiliate, Hikma Pharmaceuticals USA Inc. The first Hikma medicine available in prefilled syringe form is Heparin Sodium Injection, USP, 5000 Units/mL.

“Medical professionals are always in need of tools that help them improve the speed, safety and accuracy of patient care, and that is why Hikma is excited to launch our prefilled syringe capability,” said Dan Motto, Hikma’s EVP of Commercial & Business Development, US Injectables. “Our Heparin Sodium Injection prefilled syringes are ready-to-administer and will help hospitals, pharmacists, doctors and nurses treat patients faster, more easily and with reduced risk. This is another example of how Hikma is using its capabilities as a leading generic pharmaceutical company to serve the growing needs of US medical professionals and their patients.” 

“Hikma is continuously expanding its broad and deep portfolio of essential injectable medicines” said Riad Mishlawi, President, Hikma Injectables. “We have made significant investments in our US manufacturing capabilities to bring this new prefilled syringe capability to market, and Heparin is the first of many important medicines we will deliver in this form.”

Hikma is the third largest U.S. supplier of generic injectable medicines by volume, with a portfolio of over 100 products.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics